Oklahoma City, OK, United States of America

Doris Manglaracina Benbrook

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Doris Manglaracina Benbrook: Innovator in Pharmaceutical Sciences

Introduction

Doris Manglaracina Benbrook is a notable inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug compositions and treatment methods. With a total of 3 patents, her work has the potential to impact various medical conditions.

Latest Patents

One of her latest patents is focused on nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof. This invention discloses microparticulate drug compositions that comprise nanocrystals of poorly soluble drugs combined with a carrier. Additionally, it includes pharmaceutical compositions that utilize these microparticulate drug compositions. Another significant patent involves the treatment and inhibition of disease conditions using flexible heteroarotinoids. This invention outlines methods for treating, reducing, inhibiting, or preventing several diseases, including cancers, diabetes, and high cholesterol, among others.

Career Highlights

Doris has worked with the University of Oklahoma, where she has contributed to research and development in her field. Her innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Throughout her career, Doris has collaborated with notable individuals such as Kenneth D. Berlin and Eldon C. Nelson. These collaborations have further enriched her research and development efforts.

Conclusion

Doris Manglaracina Benbrook is a pioneering inventor whose work in pharmaceutical sciences continues to advance medical treatments. Her patents reflect her commitment to improving health outcomes through innovative drug compositions and methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…